Overview of recent topics in clinical pharmacology of anticancer agents (Q77337877)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9750026%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

review article

1 reference

title

Overview of recent topics in clinical pharmacology of anticancer agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9750026%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

1 reference

M J Egorin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9750026%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9750026%20AND%20SRC:MED&resulttype=core&format=json

Cancer Chemotherapy and Pharmacology

4 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9750026%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

volume

42 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9750026%20AND%20SRC:MED&resulttype=core&format=json

4 December 2019

page(s)

S22-30

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9750026%20AND%20SRC:MED&resulttype=core&format=json

Successful Pneumocystis carinii pneumonia prophylaxis using aerosolized pentamidine in children with acute leukemia

4 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Quantitation of 4-hydroxycyclophosphamide/aldophosphamide in whole blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Phase I trial of doxorubicin with cyclosporine as a modulator of multidrug resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Amifostine (Ethyol): dosing, administration and patient management guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Carboplatin dosage: prospective evaluation of a simple formula based on renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Prediction of carboplatin clearance from standard morphological and biological patient characteristics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Optimal sampling times for pharmacokinetic experiments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Determination of extracellular methotrexate tissue levels by microdialysis in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Aging and Cancer: Issues of Basic and Clinical Science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Fighting cancer by attacking its blood supply

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

A single-sample assay for the estimation of the area under the free carboplatin plasma concentration versus time curve

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Saturation of 2',2'-difluorodeoxycytidine 5'-triphosphate accumulation by mononuclear cells during a phase I trial of gemcitabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Gemcitabine in leukemia: a phase I clinical, plasma, and cellular pharmacology study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Liposomal-entrapped doxorubicin: an active agent in AIDS-related Kaposi's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Cardioprotection by dexrazoxane (Cardioxane; ICRF 187): progress in supportive care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Kinetics of pharmacologic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Liposomal formulations of cytotoxic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Relationships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

A population model for the leukopenic effect of etoposide*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Clinical Pharmacokinetic Considerations in the Elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Phase I/II trial of dexverapamil plus vinblastine for patients with advanced renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Phase I and pharmacologic study of topotecan in patients with impaired renal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Farnesyl: proteintransferase inhibitors as agents to inhibit tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Clinical development of anticancer agents from natural products

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

High-performance capillary electrophoresis measurement of dolastatin-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Impact of cyclophosphamide on relationships between carboplatin exposure and response or toxicity when used in the treatment of advanced ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Induced differentiation, the cell cycle, and the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Cremophor pharmacokinetics in patients receiving 3-, 6-, and 24-hour infusions of paclitaxel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Telomerase activity in human cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

The population approach to pharmacokinetic data analysis: rationale and standard data analysis methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

High-performance liquid chromatographic assay for cytosine arabinoside, uracil arabinoside and some related nucleosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Salivary excretion of anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Alternative approaches to estimation of population pharmacokinetic parameters: comparison with the nonlinear mixed-effect model

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Salivary drug monitoring of irinotecan and its active metabolite in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Antisense oligodeoxynucleotides as clinical therapeutic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Kinetics of pharmacologic response I. Proposed relationships between response and drug concentration in the intact animal and man

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Ifosfamide clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Simple and versatile high-performance liquid chromatographic method for the simultaneous quantitation of the lactone and carboxylate forms of camptothecin anticancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Plasma alcohol concentrations in patients following paclitaxel infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Hypersensitivity reactions from taxol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Positron emission tomography: a new investigational area for cancer research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Matrix metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076

Phase I trial of etoposide with cyclosporine as a modulator of multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS002800051076